1-1 of 1
John Climax
Close
Sort by
Journal Articles

A Phase 2, Open-Label Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients with Sickle Cell Disease

Biree Andemariam, Vivien A. Sheehan, Moayed Hamza, Kirsty Kelly, John Climax
Journal: Blood
Blood (2023) 142 (Supplement 1): 1159.
https://doi.org/10.1182/blood-2023-188727
Published: 2023